Recombinant Human Interferon α-2b Spray
It is the first Interferon spray in the world, indicated for the

treatment of primary and recurrence oral and genital herpes simplex

and condyloma accuminatum.

With the advanced technology of protein transdermal drug delivery

systems and non-contact quantitative spray, Interferon binds to mucous

cell-surface receptors to inhibit virus replication directly, which

frees the patient suffering from pain of injection or embrocate

administration and avoids cross-infection as well.

Jaferon Spray is special for its convenience, prompt effect, safety

and sanitation, no obvious adverse reactions.